The ESMO Congress is a globally influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2024 will disseminate the latest cutting-edge data, provide high quality education and excellent networking opportunities for oncologists and other stakeholders from all around the world. The innovative ...
ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO. Via Ginevra 4, 6900 Lugano - CH
The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) announce that Filippo de Marinis, Director of the Thoracic Oncology Division at the European Institute of Oncology (IEO) in Milan, is the recipient of the 2026 Heine H. Hansen (HHH) Award
EurekAlert!: ESMO publishes first guidance on the safe use of Large Language Models in oncology practice
Lugano/Berlin, 20 October 2025 – The European Society for Medical Oncology (ESMO) released today the ESMO Guidance on the Use of Large Language Models in Clinical Practice (ELCAP), the first ...
ESMO publishes first guidance on the safe use of Large Language Models in oncology practice
EurekAlert!: ESMO releases version 2.0 of the Magnitude of Clinical Benefit Scale
Lugano, Switzerland, 23 May 2025 – The European Society for Medical Oncology (ESMO) is pleased to announce the publication of the latest version of the scale that ...
News Medical: ESMO releases updated scale to measure clinical benefit of cancer treatments
"The release of ESMO-MCBS v2.0 marks a major step forward in ESMO's mission to promote value-based cancer care, and clearly reflects ESMO's ongoing commitment to ensuring that the scale remains a ...